￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Contraindications and people who should use Pemetinib with caution

2026-02-01 22:25:32

Check Details
Guide to identifying the authenticity of the Lao version of pemetinib (pemetinib)

2026-02-01 22:25:32

Check Details
How many boxes of pemetinib should a patient with cholangiocarcinoma take a month and how much does it cost?

2026-02-01 22:25:32

Check Details
The original manufacturer and drug description of Dabotan pemetinib

2026-02-01 22:25:32

Check Details
2024 Pemetinib (Pemetinib) Buying Guide and Price Reference

2026-02-01 22:25:32

Check Details
Next-generation BTKis demonstrate superior efficacy and safety to ibrutinib/ibrutinib in real-world settings

2026-02-01 22:25:32

Check Details
Emergency treatment after accidentally taking ibrutinib/ibrutinib

2026-02-01 22:25:32

Check Details
Ibrutinib/Ibrutinib vs. Nintedanib: Similarities and Differences in Drug Properties and Clinical Applications

2026-02-01 22:25:32

Check Details
The difference between ibrutinib/ibrutinib and sirolimus

2026-02-01 22:25:32

Check Details
What is the connection between ibrutinib and ibrutinib

2026-02-01 22:25:32

Check Details
How long does it take for ibrutinib/ibrutinib to be effective?

2026-02-01 22:25:32

Check Details
Ensidipine Use Limitations: Patients should be cautious or avoid taking ensidipine under these circumstances

2026-02-01 22:25:32

Check Details
Category
相关知识